|
|
| 2024 |
|
2024 AB1426
|
RAB19 AND PANCREATIC INJURY IN PATIENTS TAKING AZATHIOPRINE: A GENOME-WIDE ASSOCIATION STUDY,
S. Shah, T. Reese, L. Daniel, P. Nepal, J. Zanussi, A. Dickson, R. Tao, A. Hung, W. Q. Wei, C. M. Stein, Q. Feng, C. Chung
|
|
2024 AB1428
|
ADALIMUMAB AND TOCILIZUMAB BIOSIMILARS IN EUROPE: BUDGET-IMPACT AND OPPORTUNITY FOR EXPANDED PATIENT ACCESS,
K. Shastri, K. Clarke, M. Ainslie-Garcia, N. Ferko
|
|
2024 AB1429
|
SOCIODEMOGRAPHIC AND CLINICAL FACTORS ASSOCIATED WITH HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES TREATED WITH GLUCOCORTICOIDS: A CROSS-SECTIONAL STUDY,
K. W. Lim, S. Janagan, R. Bhogal, S. Bridgewater, C. Silverthorne, P. Richards, J. Dawson, E. Dures, C. Hill, S. Goodman, S. Mackie, M. Ndosi, J. C. Robson
|
|
2024 AB1430
|
FACTORS ASSOCIATED WITH REMOTE RECRUITING IN PATIENT CENTERED OUTCOMES RESEARCH STUDIES,
J. R. Curtis, C. Clinton, E. Holladay, C. Curtis, F. Xie, P. Stewart, B. Nowell
|
|
2024 AB1431
|
THE BUDGET IMPACT OF A TOCILIZUMAB BIOSIMILAR: A SPANISH PAYER PERSPECTIVE,
K. Shastri, K. Clarke, M. Ainslie-Garcia, K. Szafranski, N. Ferko
|
|
2024 AB1432
|
DISTINCT IMMUNOLOGICAL SIGNATURES OF AIIRD PATIENTS FROM IMMUNOPHENOTYPING ANALYSIS,
K. J. Park, Y. N. Cho, H. M. Jin, H. J. Jung, H. M. Jeong, S. E. Choi, J. H. Kang, D. J. Park, T. J. Kim, S. S. Lee, Y. W. Park
|
|
2024 AB1433
|
APPLICATION OF BIOINFORMATICS ANALYSIS TO IDENTIFY SHARED HUB GENES AND PATHWAYS IN IDIOPATHIC PULMONARY FIBROSIS AND RHEUMATOID ARTHRITIS-ASSOCIATED USUAL INTERSTITIAL PNEUMONIA,
X. Zhang, L. Chen, H. Lin, L. Qin, D. Huang, P. Chen
|
|
2024 AB1434
|
CELLULAR RESPONSE TO CHEMICAL STIMULUS AND REACTIVE OXYGEN SPECIES ASSOCIATED PATHWAYS IN THE PATHOGENESIS IN SJÖGREN SYNDROME, SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER AUTOIMMUNE DISEASES: A MOLECULAR PATHWAY ENRICHMENT ANALYSIS,
S. E. Rojas Gutierrez, R. Martinez-Canales, C. Elizondo Solis, M. Gelinas Martin del Campo, M. Montelongo Rojas, G. Banda Morales, A. Montoya Rosales, N. Macias-Segura, M. Salinas Carmona
|
|
2024 AB1435
|
BUDGET IMPACT ANALYSIS OF A TOCILIZUMAB BIOSIMILAR: A UK PAYER PERSPECTIVE,
K. Shastri, K. Clarke, M. Ainslie-Garcia, K. Szafranski, N. Ferko
|
|
2024 AB1436
|
TO WHAT EXTENT IS THERE A HALO EFFECT ON CLASS PRESCRIBING ACROSS KEY RHEUMATOLOGY INDICATIONS (RA, PsA AND axSpa)?,
S. Brown, J. Godfrey, M. Hollis, R. Samuels, M. I. Tanase
|
|
2024 AB1437
|
NON-PDL1 BLOCKING PD1 AGONISTIC ANTIBODIES MAY INDUCE PRO-INFLAMMATORY CYTOKINES PRODUCTION IN VITRO,
Y. Orlovsky, L. Y. Hao, M. Swiecki, S. Cole, S. Dutta, I. White
|
|
2024 AB1438
|
CYTOKINE LEVELS IN COLOMBIAN FEMALE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS AND THEIR CORRELATION WITH BLOOD AND CLINICAL PARAMETERS,
N. Duarte, L. S. Rodriguez, K. Segura, C. Tovar, S. Cacciatore, J. M. Bello-Gualtero, O. Gómez, S. Amado, D. G. Fernández-Ávila, M. C. Romero, S. Pulido
|
|
2024 AB1439
|
UPDATE OF THE EULAR POINTS TO CONSIDER FOR USE OF ANTIRHEUMATIC DRUGS IN REPRODUCTION, PREGNANCY AND LACTATION,
F. Förger, A. Pluma Sanjurjo, L. Rüegg, S. Hamroun, I. Cecchi, L. F. Perez, P. Anderson, L. Andreoli, S. Badreh, V. Boyadzhieva, C. Chambers, N. Costedoat-Chalumeau, R. J. E. M. Dolhain, R. Fischer-Betz, I. Giles, C. Götestam Skorpen, M. Hoeltzenbein, F. Marchiori, K. Mayer-Pickel, A. Moltó, C. Nelson-Piercy, O. H. Nielsen, A. Tincani, M. Wallenius, A. Zbinden, Y. Meissner, A. Finckh On Behalf of: EULAR Task force in as Working Group: “EULAR task force QoC 012: Update of the EULAR Points to Consider for Use of Antirheumatic Drugs in Reproduction, Pregnancy and Lactation”
|
|
2024 AB1440
|
EULAR RECOMMENDATIONS FOR THE INVOLVEMENT OF PATIENT RESEARCH PARTNERS IN RHEUMATOLOGY RESEARCH: 2023 UPDATE,
M. De Wit, K. Aouad, M. Elhai, D. Benavent, H. Bertheussen, C. Zabalan, J. Primdahl, P. Studenic, L. Gossec O. B. O. T. E. T. F. For Prp Involvement On Behalf of EULAR Taskforce for Updating the EULAR PRP Recommendations
|
|
2024 AB1441
|
MAPPING EULAR’S EDUCATIONAL INITIATIVES TO THE EULAR-UEMS STANDARDS FOR TRAINING OF EUROPEAN RHEUMATOLOGISTS,
F. Sivera, A. Alunno, M. Holland-Fischer, S. Magni-Manzoni, P. Mandl, A. Pfeil, S. Piantoni, S. Ramiro, C. J. Edwards
|
|
2024 AB1442
|
PREDICTIVE FACTORS FOR DOSE REDUCTION AND DISCONTINUATION OF NINTEDANIB IN FIBROTIC INTERSTITIAL LUNG DISEASES: A REAL-LIFE, SINGLE-CENTER STUDY,
C. Ferreira, E. Costa, P. Pereira, A. M. Correia, A. R. Pedroso, R. Matos, M. Cunha Rodrigues, E. Padrão, J. Silva, J. Neves, R. Rolo
|
|
2024 AB1443
|
CONSISTENT SAFETY PROFILE OF SECUKINUMAB IN PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: UPDATE ON THE DATA FROM POOLED CLINICAL TRIALS,
A. Deodhar, I. B. Mc Innes, X. Baraliakos, A. B. Gottlieb, U. Kiltz, S. Schreiber, B. G. Sahoo, W. Bao, L. Pricop, C. Gaillez, V. Dong, P. J. Mease
|
|
2024 AB1444
|
ELECTRONIC HEALTH LITERACY IN PATIENTS WITH RMDS AND ITS ASSOCIATION WITH DISEASE ACTIVITY – A CROSS – SECTIONAL STUDY,
N. Nakhost Lotfi, H. Lechner-Radner, P. Studenic
|
|
2024 AB1445
|
RETHINKING PREDICTORS: SJOGREN’S SYNDROME AS A POSITIVE PREDICTOR OF RITUXIMAB EFFECTIVENESS IN RHEUMATOID ARTHRITIS,
T. Beirão, M. Diz Lopes, C. Gomes, I. Santos, M. Bernardes, L. Costa
|
|
2024 AB1446
|
ASSOCIATION OF GENETICALLY PROXIED JANUS KINASE INHIBITOR TARGETS WITH CARDIOVASCULAR RISK: A DRUG-TARGET MENDELIAN RANDOMIZATION STUDY,
L. Dai, Q. Y. Song, Y. W. Zou, Y. Su, L. W. Su, J. D. MA, J. Pan, Z. M. Ouyang, Y. Lu, T. Wu, J. Z. Lin, P. W. Jia, H. W. Zheng, J. Dai
|
|
2024 AB1447
|
IMMUNE RELATED ADVERSE EVENTS DUE TO CHECKPOINT INHIBITOR THERAPY IN CANCER PATIENTS WITH RHEUMATOID ARTHRITIS: A MEDICARE CLAIMS STUDY,
D. Jannat-Khah, F. Xie, A. Saxena, J. R. Curtis, A. Bass
|
|
2024 AB1448
|
DIFFERENTIATION OF IMMUNE MEDIATED VERSUS NON IMMUNE MEDIATED RHEUMATIC DISEASES BY ONLINE SYMPTOM CHECKER IN REAL-WORLD PATIENTS – MULTIPLE DIAGNOSES AND PARTICULARLY FIBROMYALGIA IS A STUMBLING BLOCK,
L. Qin, F. Zegers, D. Selani, E. B. Van den Akker, R. Bos, S. Le Cessie, I. Gehring, H. K. Glas, M. Johannesson, J. Knitza, L. Mathsson-Alm, M. J. T. Reinders, E. Steyerberg, A. Van Tubergen, L. M. Verhoef, B. Axnäs, L. Klareskog, R. Knevel On Behalf of Knevel Lab
|
|
2024 AB1449
|
EXPLORING VACCINATION BEHAVIOUR IN PATIENTS WITH RHEUMATIC DISEASES: FINDINGS FROM A REGISTRY-BASED STUDY (SWISS CLINICAL QUALITY MANAGEMENT),
S. Mehouachi, D. S. Courvoisier, G. Eperon, K. Lauper
|
|
2024 AB1450
|
EXPECTATIONS AND OPINIONS OF RHEUMATOLOGISTS DURING SPECIALIST TRAINING ABOUT THE EULAR-UEMS STANDARDS FOR TRAINING EUROPEAN RHEUMATOLOGISTS,
S. Piantoni, A. Alunno, K. Lauper, T. W. Kragstrup, S. Rednic, C. J. Edwards
|
|
2024 AB1451
|
NEW APPROACHES TO THE STUDY OF SOCIAL DETERMINANTS OF HEALTH: DISCOVERY, EXTRACTION AND CHARACTERISATION OF MUSCULOSKELETAL PATIENTS’ OCCUPATIONS IN THE ELECTRONICAL MEDICAL RECORD USING DEEP LEARNING AND PRE-TRAINED LANGUAGE MODELS,
A. Madrid García, I. Pérez - Sancristóbal, L. León, L. Abasolo, A. Rodríguez González, B. Fernández-Gutiérrez, E. Menasalvas Ruiz, L. Rodriguez Rodriguez
|
|
2024 AB1452
|
HOW CANCER LOCATION AND TIMING DIFFER BETWEEN INFLAMATORY MYOPATHY AND IGA VASCULITIS,
A. Hocevar, K. Perdan-Pirkmajer, Z. Rotar
|
|
2024 AB1453
|
PYROPTOTIC GENES AS PREDICTORS OF BONE RESORPTION AND MINERALIZATION IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS,
Z. Yang, M. MA, Y. Liang, Y. Wen, P. Zhang, R. Huang
|
|
2024 AB1454
|
RETROSPECTIVE CLINICAL DATA OF IMMUNE THERAPY RELATED RHEUMATOLOGICAL ADVERSE EVENTS IN THE AMSTERDAMUMC RHEUMATOLOGY OUTPATIENT CLINIC,
W. Van Binsbergen, M. Labots, C. J. Van der Laken
|
|
2024 AB1455
|
EXPLORING THE RISK, CAUSALITY RELATIONSHIP AND MOLECULAR MECHANISM BETWEEN SYSTEMIC LUPUS ERYTHEMATOSUS AND THYROID CANCER: A META, MENDELIAN RANDOMIZATION AND TRANSCRIPTOME ANALYSES,
S. Liu, H. Chen, Q. Sun, Y. Liu, X. Yuan, D. Wang, L. Sun
|
|
2024 AB1456
|
EVALUATING THE PARTICIPATION OF JUNIOR, PATIENT AND HEALTH CARE PROFESSIONALS REPRESENTATIVES IN EULAR TASK FORCES: RESULTS FROM AN INTERNATIONAL SURVEY,
P. A. Juge, T. W. Kragstrup, L. F. Perez, E. Mateus, S. Makri, P. Boyd, J. Primdahl, R. J. O. Ferreira, T. P. M. Vliet Vlieland, M. Ndosi, U. Kiltz, R. Landewé, K. Lauper, M. De Hooge
|
|
2024 AB1457
|
ABNORMAL STANDARD BLOOD CARDIAC BIOMARKERS DO NOT IDENTIFY CARDIOVASCULAR MRI ABNORMALITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS,
H. N. Cheema, R. R. Shukla, R. Dumitru, S. Plein, M. Buch
|
|
2024 AB1458
|
RHEUMATIC DISEASES AND BEYOND: THE KOMO-R STUDY ON COMORBIDITIES, CANCER SCREENING AND VACCINATION PATTERNS,
A. Hueber, V. Bartsch, K. Standfest, J. Knitza, G. Schett
|
|
2024 AB1459
|
SCENARIO-BASED POINT OF CARE RHEUMATOLOGY ULTRASOUND (POCRUS): A REPORT FROM THE APLAR ONLINE COURSE (2022-2023),
A. Lee, L. C. Chew, A. Abogamal, P. Balint, G. Harifi, K. Ikeda, M. Khurshid, K. O. Kong, K. L. Lai, K. W. G. Lee, R. J. Wakefield, B. Dasgupta
|
|
2024 AB1460
|
DEVELOPMENT STRATEGIES AND THEORETICAL UNDERPINNINGS OF SMARTPHONE APPS TO SUPPORT SELF-MANAGEMENT OF RHEUMATIC AND MUSCULOSKELETAL DISEASES: A SYSTEMATIC LITERATURE REVIEW,
R. Barnett, C. Clarke, R. Sengupta, P. C. Rouse
|
|
2024 AB1461
|
ASSOCIATION OF FLARES OF CONNECTIVE TISSUE DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS WITH DRUG USE FOLLOWING COVID-19 MRNA VACCINATION: RESULTS FROM THE CORONAVIRUS NATIONAL VACCINE REGISTRY FOR IMMUNE DISEASES SINGAPORE (CONVIN-SING),
P. Dhanasekaran, A. Mak, M. MA, Y. H. Chan, A. Santosa, P. Cheung, W. Fong, S. Angkodjojo, C. Xu, K. O. Kong, T. Arkachaisri, K. F. Phang, T. C. Tan, M. Sriranganathan, S. H. Tay, M. Lahiri
|
|
2024 AB1462
|
COMPARATIVE ASSESSMENT OF THE ACCURACY AND SATISFACTION OF RESPONSES TO E-CONSULTATIONS IN RHEUMATOLOGY: CHAT-GPT VS SPECIALISTS (CORE-RC STUDY),
R. Mazzucchelli, P. Turrado-Crespí, N. Crespí-Villarías, J. L. Andréu Sánchez, J. Dorado, J. A. García-Vadillo, C. Carvajal, J. Quiros Donate, I. Sanchez, N. Puyo, R. Almodóvar, P. Zarco-Montejo, C. Pijoán-Moratalla, E. Pérez-Fernández
|
|
2024 AB1463
|
JOINT MEETINGS ON PREGNANCY COMPLICATED BY RHEUMATIC AND MUSCULOSKELETAL DISEASES: IMPROVEMENT OF CLINICAL COORDINATION AND RESULTS IN 2022-2023,
H. Ozawa, T. Asano, M. Okada
|
|
2024 AB1464
|
TRANSITIONING BACK AND FORTH BETWEEN BIO-ORIGINATOR ETANERCEPT AND BIOSIMILAR SB4 IN CLINICAL PRACTICE: IMPACT ON DRUG SURVIVAL AND DISEASE ACTIVITY,
M. H. M. Wientjes, L. Swiggers, V. Huiskes, B. Van den Bemt, D. Ten Cate, L. Tweehuysen, A. A. Den Broeder, N. Van Herwaarden
|
|
2024 AB1465
|
WHY DO CLINICIANS REQUEST BDMARD DRUG LEVELS? RETROSPECTIVE REVIEW OF OVER 8000 REQUESTS,
M. Perry, C. Kuah
|
|
2024 AB1466
|
PERSISTING GENDER DISPARITIES IN RHEUMATOLOGY RESEARCH: AN ANALYSIS OF AUTHORSHIP TRENDS IN RANDOMISED CONTROLLED TRIALS,
K. Lauper, D. S. Courvoisier, M. Iudici, D. Mongin
|
|
2024 AB1467
|
EFFECTIVENESS OF TELEMEDICINE IN RHEUMATOLOGY: A MULTI-SITE RANDOMIZED, SINGLE-BLIND, PARALLEL GROUP, NONINFERIORITY TRIAL IN THE UNITED STATES,
L. Jackson, J. Leach, J. Yazdany, K. Saag, J. R. Curtis, D. Paez, S. Goglin, M. Margaretten, D. Chae, G. Cutter, M. Danila
|
|
2024 AB1468
|
ATTAINMENT OF GUIDELINE-RECOMMENDED CHOLESTEROL GOALS IN CARDIOVASCULAR PREVENTION - RESULTS FROM A PREVENTIVE CARDIO-RHEUMA CLINIC IN NORWAY,
E. J. P. Sollerud, E. Ikdahl, J. Sexton, A. Eirheim, A. G. Semb On Behalf of Preventive Cardio-Rheuma Clinic, REMEDY Centre for Treatment of Rheumatic and Musculoskeletal Diseases
|
|
2024 AB1469
|
PROSPECTIVE REGISTRATION IN RHEUMATOLOGY RANDOMIZED CONTROLLED TRIALS: WHERE WE ARE, WHY, AND HOW WE COULD GET BETTER,
S. Capderou, D. Mongin, T. Agoritsas, D. S. Courvoisier, M. Iudici
|
|
2024 AB1470
|
IMAGING OF INTRAMUSCULAR PATHOLOGY BY [18F]-FDG POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH RHEUMATIC MUSCULOSKELETAL DISEASES,
M. Sobejana, M. Al Beiramani, G. J. C. Zwezerijnen, A. J. Van der Kooi, C. Meskers, M. Van der Esch, C. J. Van der Laken, M. M. Steinz
|
|
2024 AB1471
|
MACHINE-LEARNING BASED MODELS ASSIST THE IDENTIFICATION OF PULMONARY EMBOLISM IN AUTOIMMUNE DISEASES-A RETROSPECTIVE, MULTICENTER STUDY,
L. Dong
|
|
2024 AB1472
|
MALE PERSPECTIVE ON REPRODUCTIVE HEALTH IN RHEUMATOLOGY PATIENTS: A CROSS-SECTIONAL STUDY,
E. Giacobbe, M. C. Gerardi, C. Gagliardi, S. Benedetti, G. DI Raimondo, A. Ascione, M. Barichello, N. Ughi, A. Adinolfi, L. Belloli, C. Casu, M. DI Cicco, D. A. Filippini, M. Longhi, B. L. Palermo, M. Schettino, G. Segatto, E. Verduci, O. M. Epis
|
|
2024 AB1473
|
HEALTH-RELATED QUALITY OF LIFE IN ANTENATAL WOMEN WITH RHEUMATIC DISEASES: INSIGHTS USING PROMIS INSTRUMENTS FROM THE COVAD 2 DATASET,
S. Abe, Y. LI, V. Maroufy, L. Andreoli, S. Ghosh, E. Nikiphorou, M. Javaid, A. E. Gracia-Ramos, S. S. Shaharir, C. E. Toro-Gutierrez, D. Dzifa, R. Aggarwal, V. Agarwal, L. Gupta On Behalf of COVAD Study Group
|
|
2024 AB1474
|
NINTEDANIB IN AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASE: REAL-LIFE EFFECTIVENESS, SAFETY AND TOLERANCE IN A SPANISH MULTICENTER STUDY,
P. Pérez-García, M. Retuerto-Guerrero, Y. Chuquimia, L. Sierra Herránz, J. Loarce-Martos, B. Atienza-Mateo, C. Merino Argumánez, M. Pavía Pascual, B. Miguel Ibáñez, J. Ordas Martínez, P. Baenas González, C. Sieiro Santos, C. Moriano, I. González, C. Díez, I. González Fernández, C. Álvarez Castro, E. Gutierrez, E. Diez Álvarez
|
|
2024 AB1475
|
ELDERLY ONSET RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: A COMPARATIVE STUDY OF TWO CONSECUTIVE COHORTS,
A. Amati, M. Perino, G. Cincinelli, M. Manara, E. G. Favalli, R. F. Caporali
|
|
2024 AB1476
|
COMORBIDITIES AND THEIR RELATIONSHIP WITH SELF-PERCEIVED ORAL HEALTH IN PATIENTS WITH RHEUMATIC DISEASE,
A. K. Garza-Elizondo, F. J. Torres-Quintanilla, P. Gamez-Siller, J. A. Cardenas-de la Garza, J. C. Riega-Torres, D. A. Galarza-Delgado
|
|
2024 AB1477
|
REPRODUCTIVE HEALTH ISSUES IN WOMEN WITH AUTOIMMUNE RHEUMATIC DISEASES,
M. P. Shah, R. Handa, M. Shah, S. Budmuru, S. K. Upadhyaya
|
|
2024 AB1478
|
PREGNANCY OUTCOMES FROM A TERTIARY OBSTETRIC RHEUMATOLOGY CLINIC IN THE UNITED KINGDOM: A 10-YEAR RETROSPECTIVE AUDIT,
B. Goulden, G. Woodward, S. Jain, S. Leiner, T. Mitra, H. Nguyen, D. Nzelu, D. Williams, I. Giles
|
|
2024 AB1479
|
NON-ANTI-TNF BIOLOGIC AND TARGETED THERAPIES ARE NOT ASSOCIATED WITH INCREASED RISK OF TUBERCULOSIS IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: A COHORT STUDY IN AN ENDEMIC AREA,
E. K. M. Wong, H. So, C. H. Lam, C. K. Lau, Y. Leung, Y. Q. Yip, L. S. Tam
|
|
2024 AB1480
|
STRATIFICATION OF PATIENTS USING ADVANCED INTEGRATIVE MODELLING OF DATA ROUTINELY ACQUIRED FOR DIAGNOSING RHEUMATIC COMPLAINTS (SPIDeRR): A MULTICENTER EUROPEAN CONSORTIUM,
J. Desai, E. Van den Akker, J. Askling, B. Axnäs, A. Banos, L. Carmona, L. Christiansson, M. Hulsinga, D. De Jong, J. Knitza, H. Morf, F. Muehlensiepen, A. Pratt, G. Nagy, J. Newton, L. Rodriguez Rodriguez, D. Schiphof, S. Viatte, M. Villalobos Quesada, R. Knevel
|
|
2024 AB1481
|
TO OPTIMIZE THE DIAGNOSTIC PROCESS OF RHEUMATIC DISEASES AFFECTING THE HANDS USING FOI,
N. Stumper, J. Berger, E. Gedat, P. Hoff, G. Schmittat, G. R. Burmester, G. Krönke, M. Backhaus, I. K. Haugen, S. Ohrndorf
|
|
2024 AB1482
|
MENTAL DISORDERS AND HELP-SEEKING IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: RESULTS FROM A TERTIARY CENTRE CROSS-SECTIONAL STUDY,
T. Formanek, M. Husakova, M. Olejárova, V. Balajková, J. Juhaszova, L. Šenolt, R. Moravcova, L. Goerojova, K. Pavelka, K. Mladá, P. Winkler, P. Mohr
|
|
2024 AB1483
|
NINTEDANIB IN PROGRESSIVE PULMONARY FIBROSIS. COMPARING SUBGROUPS IN CLINICAL PRACTICE. EXPERIENCE OF PULMONOLOGISTS AND RHEUMATOLOGISTS,
P. Pérez-García, M. Retuerto-Guerrero, Y. Chuquimia, L. Sierra Herránz, J. Loarce-Martos, B. Atienza-Mateo, C. Merino Argumánez, M. Pavía Pascual, B. Miguel Ibáñez, J. Ordas Martínez, P. Baenas González, C. Sieiro Santos, C. Moriano, I. González, C. Díez, I. González Fernández, C. Álvarez Castro, E. Gutierrez, E. Diez Álvarez
|
|
2024 AB1484
|
PERFORMANCE OF THE NEW PREVENT CARDIOVASCULAR RISK CALCULATOR TO DETECT HEART FAILURE IN PATIENTS WITH RHEUMATIC DISEASES,
V. Gonzalez-Gonzalez, J. R. Azpiri-Lopez, D. A. Galarza-Delgado, I. J. Colunga-Pedraza, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera, N. Guajardo-Jauregui, M. F. Elizondo-Benitez, A. L. Guajardo-Aldaco
|
|
2024 AB1485
|
SYNOVIAL SPECIMENS’ DIAGNOSIS ACROSS DEPARTMENTS IN A PORTUGUESE TERTIARY CENTER,
C. Ochôa Matos, M. Pinho Fialho, V. Correia Fernandes, R. Moiteiro, D. Doutel, R. Luís, E. Vieira-Sousa
|
|
2024 AB1486
|
BASELINE CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISORDERS: DATA FROM A PROSPECTIVE OBSERVATIONAL COHORT FROM THE GERMAN REGISTRY LORE,
U. Kiltz, I. A. Luedemann, I. Redeker, K. De Jong, S. Tsiami, F. Alshakaki, I. Andreica, B. Guminski, U. Haeusler, D. Karagkiozidou, H. Kavruk, D. Kiefer, R. Lochowski, A. M. Patru, P. Sewerin, D. Vossen, S. Waldecker-Gall, X. Baraliakos
|
|
2024 AB1487
|
DESCRIPTIVE ANALYSIS OF MORTALITY AND ITS CAUSES IN INTENSIVE CARE UNITS OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES UNDER CONVENTIONAL TREATMENT OR BIOLOGIC THERAPY USING FRENCH NATIONAL DATABASE,
Y. Hamidou, V. Goeb, J. M. Sobhy Danial
|
|
2024 AB1488
|
IS THE FUTURE OF RHEUMATOLOGY HERE? A STUDY OF A PROPRIETARY RULE ENGINE AND ARTIFICIAL INTELLIGENCE GPT4 (AI GPT4) FOR INITIAL EVALUATION OF RHEUMATOLOGY CASES,
H. M. Badsha, B. Khan, G. Harifi, A. J, S. Raman
|
|
2024 AB1489
|
HIGH RESOLUTION COMPUTED TOMOGRAPHY (HRCT) COMPARING INTERSTITIAL LUNG DISEASE (ILD) FEATURES ACROSS CONNECTIVE TISSUE DISEASES (CTDS) TO CONSIDER IMPACT ON MORBIDITY/MORTALITY - A SCOPING REVIEW,
D. Furst, T. Woodworth, O. Morgan, N. Fathy
|
|
2024 AB1490
|
JAK INHIBITORS AND INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC AUTOIMMUNE DISEASES (SADS-ILD): A SYSTEMATIC REVIEW OF THE LITERATURE,
R. Rego Salgueiro, C. Sieiro Santos
|
|
2024 AB1491
|
QUANTIFICATION OF LUNG INVOLVEMENT IN INFLAMMATORY RHEUMATIC DISEASE-INTERSTITIAL LUNG DISEASE (IRD-ILD): A COMPARATIVE STUDY BETWEEN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS USING AI-BASED HRCT ANALYSIS,
T. Hoffmann, U. Teichgräber, B. Lassen-Schmidt, D. Renz, L. B. Brüheim, M. Krämer, P. Oelzner, J. Böttcher, F. Güttler, G. Wolf, A. Pfeil
|
|
2024 AB1492
|
CONSTRUCTION AND VALIDATION OF AN OCCUPATIONAL HISTORY QUESTIONNAIRE FOR JOB CODING AND OCCUPATIONAL EXPOSURE ASSESSMENT IN SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES,
A. C. Dens
|
|
2024 AB1493
|
PATIENT SATISFACTION AND EXPERIENCE AFTER A SWITCH TO AN ADALIMUMAB BIOSIMILAR WITH HIGH CONCENTRATION AND CITRATE-FREE: RESULTS FROM A MULTICENTRIC PROSPECTIVE REAL-LIFE STUDY,
H. Marotte, L. Gossec, V. Abitbol, E. Senbel, G. Bonnaud, X. Roblin, Y. Bouhnik, S. Nancey, N. Mathieu, J. Filippi, L. Vuitton, S. Nahon, A. Dellal, A. Denis, C. Habauzit, S. Benkhalifa, G. Bouguen
|
|
2024 AB1494
|
CLINICAL ASSOCIATIONS OF ANTI-RO52 ANTIBODIES DETECTED IN 150 PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES FROM A SINGLE REFERRAL CENTRE,
M. Renuncio-García, D. Prieto-Peña, C. Secada-Gomez, J. Irure-Ventura, M. López Hoyos, R. Blanco
|
|
2024 AB1495
|
TELEDERMATOLOGY FOR RHEUMATOLOGISTS,
G. Kenar, C. Şahin, E. I. Yazici, B. Tuğrul, A. Güner, H. Göğebakan, A. M. Gencer, H. Yarkan-Tuğsal
|
|
2024 AB1496
|
MICROCIRCULATION CHARACTERIZATION IN ANOREXIA NERVOSA PATIENTS WITH RAYNAUD’S PHENOMENON,
G. Natalello, A. Zoli, P. G. Cerasuolo, S. DI Murro, G. Alonzi, S. Fiore, V. Boni, E. De Lorenzis, C. Policola, L. Moccia, M. B. Anesini, L. Rinaldi, G. Sani, A. Pontecorvi, M. A. D’agostino, S. L. Bosello
|
|
2024 AB1497
|
USE OF bDMARDs AFTER PRECONCEPTIONAL COUNSELING IN PATIENTS WITH RHEUMATIC DISEASES DURING PREGNANCY,
A. García Fernández, F. Rengifo García, R. Senosiain Echarte, Á. Navidad Miguel, M. Á. González-Gay, J. A. Martinez Lopez
|
|
2024 AB1498
|
PULMONARY FUNCTION TRAJECTORY IN ALL SUBTYPES OF ILD AND ASSOCIATED RISK FACTORS FOR DECLINE,
S. Eisa, M. Rabbani, S. Sankar, A. Ibrahim, A. Podlasek, K. Suthar, S. Ansari, G. M. Koduri
|
|
2024 AB1499
|
BEYOND NEONATAL LUPUS: MATERNAL AND PERINATAL OUTCOMES IN WOMEN WITH ANTI-SSA AND ANTI-SSB ANTIBODIES. EXPERIENCE FROM A MULTIDISCIPLINARY CLINIC.,
M. Santos Faria, A. R. Lopes, A. Teodósio Chícharo, S. C. Barreira, P. Martins, L. Pinto, M. Rebelo, A. R. Araújo, A. R. Cruz-Machado, S. Capela
|
|
2024 AB1500
|
ELECTRONIC MDHAQ (MULTIDIMENSIONAL HEALTH ASSESSMENT QUESTIONNAIRE) FOR IPHONE OR ANDROID WITH AUTOMATED REPORT FOR PHYSICIAN ENCOUNTER NOTE,
T. Pincus
|
|
2024 AB1501
|
SAFETY AND EFFECTIVENESS OF ETANERCEPT BIOSIMILAR LBEC0101 FOR RHEUMATIC DISEASES IN SOUTH KOREA: REAL-WORLD POST-MARKETING SURVEILLANCE DATA,
B. Song, S. H. Kim, S. S. Kim
|
|
2024 AB1502
|
RELIABILITY OF DAILY ELECTRONIC PATIENT-REPORTED OUTCOME MEASURES IN PATIENTS WITH SJÖGREN’S SYNDROME, OSTEOARTHRITIS AND PSORIATIC ARTHRITIS: THE COTIDIANA PROJECT,
N. Nakhost Lotfi, H. Lechner-Radner, F. Nunes, P. Matias, R. Graca, T. Stamm, P. Studenic
|
|
2024 AB1504
|
BIOSIMILARS IN BLOOM: MATERNAL AND PERINATAL OUTCOMES IN PREGNANT WOMEN WITH RHEUMATIC DISEASES TREATED WITH BIOSIMILAR TNF INHIBITORS,
A. Teodósio Chícharo, A. R. Lopes, S. Barreira, L. Pinto, A. R. Cruz-Machado, S. Capela
|
|
2024 AB1505
|
INFLAMMATORY DISEASES AND RISK OF NEOPLASIA: IS IT THE TREATMENT OR THE DISEASE IN SINE? DATA ON THE MANAGEMENT OF INFLAMMATION IN CASE OF COEXISTENCE WITH MALIGNANCY,
E. Pelechas, E. Kaltsonoudis, N. Koletsos, Z. Tziortzioti, A. Drosos, P. V. Voulgari
|
|
2024 AB1506
|
POSTPARTUM HEMORRHAGE (PPH) OUTCOMES IN INDIVIDUALS WITH AUTOIMMUNE RHEUMATIC DISEASES (ARDS) IN COMPARISON TO INDIVIDUALS WITHOUT ARDS: INSIGHTS FROM NATIONAL INPATIENT SAMPLE 2015-2019,
S. Piplani, V. Jelic, S. T. Kolli, J. Reet, V. R. Bejugam, S. R. Goguri, H. Sandhu, C. Chao, M. Radulovic, C. Tagoe, B. Johnson
|
|
2024 AB1507
|
HOW TO IMPROVE SEXUAL AND REPRODUCTIVE HEALTH CARE TO FEMALE AND MALE PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: THE EXPERIENCE OF A REPRODUCTIVE HEALTH COUNSELLING CLINIC,
E. Giacobbe, M. C. Gerardi, C. Gagliardi, S. Benedetti, G. DI Raimondo, A. Ascione, M. Barichello, N. Ughi, A. Adinolfi, L. Belloli, C. Casu, M. DI Cicco, D. A. Filippini, M. Longhi, B. L. Palermo, M. Schettino, G. Segatto, E. Verduci, O. M. Epis
|
|
2024 AB1508
|
IMPACT OF A MULTIMODAL TRAINING IN INTERVENTIONAL RHEUMATOLOGY ON THE PRACTICE OF ULTRASOUND-GUIDED PROCEDURES,
M. Bauerheim, P. Arnolfo, J. Gross, J. Maillet, G. Cormier, S. Varin, B. Le Goff, C. Darrieutort-Laffite
|
|
2024 AB1509
|
MATERNAL-FETAL OUTCOMES OF PREGNANT WOMEN WITH SYSTEMIC AUTOIMMUNE DISEASES: EFFICACY AND SAFETY OF ASSISTED REPRODUCTIVE TECHNIQUES IN THREE TERTIARY CARE CENTER IN ITALY,
V. Canti, L. Cavallo, R. De Lorenzo, A. Calligaro, F. Ruffilli, M. Tonello, P. Melissa, L. Quaranta, V. S. Vanni, F. Pasi, E. Papaleo, B. Maranini, M. Govoni, A. Doria, P. Rovere-Querini On Behalf of Gender Medicine - SIR
|
|
2024 AB1510
|
A SIX-YEAR RETROSPECTIVE ANALYSIS OF PREGNANCY OUTCOMES IN A MULTIDISCIPLINARY OBSTETRIC-MEDICINE/RHEUMATOLOGY SPECIALTY CLINIC IN THE UNITED STATES,
S. Jafari-Esfahani, M. Deeb, J. Mathew, A. Reginato, G. Tarabulsi, J. Szczygiel-Cunha
|
|
2024 AB1511
|
PERCEIVED NEED FOR TREATMENT IS ASSOCIATED WITH PATIENT SATISFACTION AFTER A SWITCH TO A BIOSIMILAR; HEALTH LITERACY IS OFTEN LIMITED: A PROSPECTIVE MULTICENTRE OBSERVATIONAL STUDY OF 232 PATIENTS,
L. Gossec, G. Bouguen, H. Marotte, L. Foulley, C. Habauzit, S. Benkhalifa, V. Abitbol
|
|
2024 AB1512
|
INFRARED THERMOGRAPHY AS A SCREENING TOOL FOR SECONDARY RAYNAUD’S PHENOMENON: A DIAGNOSTIC TEST STUDY,
V. Vasdev, G. Singh, K. Sivasami, A. Kumar
|
|
2024 AB1513
|
ECONOMIC IMPACT AND CLINICAL OUTCOMES WITH THE SWITCH TO BIOSIMILARS IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS IN A SPECIALIZED CENTER IN BOGOTÁ-COLOMBIA,
E. Jauregui, D. Restrepo, J. Palacio, J. A. Chaparro, R. A. Mejia Romero, J. Salazar, A. Rodriguez On Behalf of Programa PARATI de Enfermedades Autoinmunes
|
|
2024 AB1514
|
PERFORMANCE OF A NOVEL, FULLY AUTOMATED MULTIPLEXED IMMUNOASSAY MICROARRAY FOR THE SEROLOGICAL DETECTION OF ELEVEN AUTOANTIBODIES COMMONLY FOUND IN CONNECTIVE TISSUE DISEASES AND CLINICAL DIAGNOSIS OF REACTIVE SAMPLES,
P. Ghillani-Dalbin, C. Daubrosse, V. Mercier, D. Bijlsma, E. Lukasik, R. Pasion Galvan, V. Botti, G. Gomez, E. Moreau, M. Hausmann, C. C. Ginocchio, M. Miyara
|
|
2024 AB1515
|
ASSESSMENT AND COMPARISON OF LONG-TERM SKILL RETENTION FOLLOWING TELEDIDACTIC MUSCULOSKELETAL ULTRASOUND TRAINING FOR MEDICAL STUDENTS – THE TELMUS FOLLOW-UP STUDY,
R. Neubauer, C. J. Bauer, S. M. Petzinna, F. Recker, V. S. Schaefer
|
|
2024 AB1516
|
SYSTEMATIC ASSESSMENT OF REGULATOR ADVICE ABOUT ANTI-RHEUMATIC DRUGS USE IN PREGNANCY – AN INTERIM ANALYSIS FROM THE EU, UK, USA, CANADA, BRAZIL AND JAPAN,
N. Surlemont Schmidt, H. Ozawa, F. Signorelli, C. Graversgaard, D. Andrade, L. Andreoli, K. Schreiber
|
|
2024 AB1517
|
TIME TO TALK TO ADULT PATIENTS ABOUT HERPES ZOSTER VACCINATION,
L. Boekel, M. Pier, G. J. Wolbink
|
|
2024 AB1518
|
ANALYTICAL PERFORMANCE OF A NOVEL, FULLY AUTOMATED MULTIPLEXED MICROARRAY IMMUNOASSAY PROTOTYPE FOR THE SIMULTANEOUS DETECTION OF FIFTEEN AUTOANTIBODIES ASSOCIATED WITH CONNECTIVE TISSUE DISEASES,
D. Bijlsma, E. Lukasik, M. Hausmann, G. Gomez, C. Fischer, P. Ghillani-Dalbin, M. Miyara, E. Moreau
|
|
2024 AB1519
|
EARLY PREDICTION OF PULMONARY HYPERTENSION IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASE WITH TRANSTHORACIC ECHOCARDIOGRAPHY AND SPO2 IN 6MWT,
S. Ishigaki, H. Hanaoka, T. Hiraide, Y. Kaneko
|
|
2024 AB1520
|
THE PERSPECTIVE OF DUTCH HEALTH CARE PROFESSIONALS ON THE USE OF ARTIFICIAL INTELLIGENCE IN RHEUMATOLOGY,
L. M. Verhoef, H. J. Bernelot Moens, N. Steinz, H. E. Vonkeman, R. Knevel
|
|
2024 AB1521
|
DIFFERENCES IN DISABILITY OF THE UPPER EXTREMITY AMONG PATIENTS WITH INFLAMMATORY AND NON-INFLAMMATORY RHEUMATIC DISEASES,
J. A. Davila-Jimenez, G. Garcia-Arellano, M. F. Elizondo-Benitez, V. Carrillo-Torres, D. A. Galarza-Delgado
|
|
2024 AB1522
|
COMPARATIVE EFFECTIVENESS OF OSTEOPOROSIS MEDICATIONS ON DISEASE ACTIVITY IN RHEUMATIC MUSCULOSKELETAL DISORDERS,
A. Giollo, A. Cuberli, M. Salvato, F. Frizzera, A. Doria
|
|
2024 AB1523
|
TUBERCULOSIS UNDER BIOTHERAPY IN CHRONIC INFLAMMATORY RHEUMATISMS: A COHORT STUDY,
S. Zaher, K. Nassar, A. Ajerouassi, S. Janani
|
|
2024 AB1524
|
EXPLORING THE SAFETY AND EFFECTIVENESS OF BIOSIMILARS BIOLOGICAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS DURING PREGNANCY,
G. Fontana, G. I. Gozzoli, D. Lini, C. Nalli, L. Andreoli, A. Tincani, F. Franceschini
|
|
2024 AB1525
|
DARATUMUMAB FOR REFRACTORY SYSTEMIC RHEUMATIC DISEASES: A SINGLE CENTER EXPERIENCE,
M. T. Holzer, I. Kötter, T. Xiong, N. Ruffer, F. C. Feindt, S. Melderis, O. M. Steinmetz, T. B. Huber, M. Krusche
|
|
2024 AB1526
|
POPULATION PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSES OF OBEXELIMAB IN HEALTHY VOLUNTEERS AND IN PATIENTS WITH RHEUMATOID ARTHRITIS OR IgG4-RELATED DISEASE,
X. Wang, R. Kirk, H. Mu, T. Fischer
|
|
2024 AB1527
|
BEYOND WHAT IS FREQUENT: PREGNANCY OUTCOMES IN RARE CONNECTIVE TISSUE DISEASES,
A. R. Lopes, A. Teodósio Chícharo, M. Santos Faria, P. Martins, S. C. Barreira, M. Centeno, L. Pinto, A. R. Cruz-Machado, S. Capela
|
|
2024 AB1528
|
BODY COMPOSITION AFTER NUTRITIONAL ORIENTATION IN OVERWEIGHT AND OBESE PATIENTS WITH RHEUMATIC DISEASES,
F. J. Torres-Quintanilla, A. K. Garza-Elizondo, J. C. Riega-Torres, K. Salinas-Zamora, P. R. Ancer-Rodriguez, J. A. Cardenas-de la Garza, D. A. Galarza-Delgado
|
|
2024 AB1529
|
DIVERSE PREVALENCE OF ANTI-C1Q ANTIBODIES ACROSS AUTOIMMUNE AND OTHER CHRONIC DISEASES,
Y. Jiang, Y. Liang, Q. Wei, J. Xie, Z. Wu, Z. Liao, J. Gu
|
|
2024 AB1530
|
AN INTEGRATIVE APPROACH TO SYSTEMIC IMMUNE-MEDIATED DISEASES: A HOSPITAL-BASED INTERVENTION STUDY,
S. Salvucci, F. Gazzoli, R. Santangeli, E. Filippini, M. Leo, L. Lucarelli, A. Festa, L. Manfredi, G. Moroncini
|
|
2024 AB1531
|
PERITENON EXTENSOR TENDON INFLAMMATION PATTERN ON MCP JOINTS IS FREQUENTLY DETECTED WITH ULTRASOUND IN PATIENTS WITH CONNECTIVE TISSUE DISEASES AS WELL AS SPONDYLARTHRITIS,
Y. Kondo, K. Hiramoto, K. Furuhashi, Y. Kaneko
|
|
2024 AB1532
|
INSIGHTS INTO THE MENTAL HEALTH OF INDIVIDUALS WITH SYSTEMIC AUTOIMMUNE DISEASE DURING PREGNANCY: PRELIMINARY RESULTS,
F. Cruz-Sanabria, D. Zucchi, E. Elefante, F. Serrago, S. Gori, F. Monacci, C. Letto, V. Gelsi, C. Tani, M. Mosca
|
|
2024 AB1533
|
ANTI-RO52 POSITIVITY IS ASSOCIATED WITH POORER LUNG FUNCTION AT DIAGNOSIS IN CONNECTIVE TISSUE DISEASE AND IDIOPATHIC INFLAMMATORY MYOPATHY ASSOCIATED INTERSTITIAL LUNG DISEASE,
R. Harrington, R. Conway, R. Fahy
|
|
2024 AB1534
|
CHARTING EXCELLENCE: DISCOVERING VALUABLE INSIGHTS THROUGH A SINGLE-CENTER RETROSPECTIVE ANALYSIS OF IN-PATIENT RHEUMATOLOGY REGISTRIES,
C. L. Tan, A. H. Ramlan, S. C. Ng, C. H. Lim
|
|
2024 AB1535
|
A PROFILE OF SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION (SARD-PAH) FROM WESTERN INDIA: A SINGLE CENTRE RETROSPECTIVE STUDY,
S. Jagennath, A. Kumar P H, R. Choudhary, M. K. Garg, M. Gopalakrishnan
|
|
2024 AB1536
|
MYCOPHENOLATE MOFETIL VERSUS RITUXIMAB IN THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES,
C. Navarro Joven, M. Alonso de Francisco, M. Machattou, P. Navarro Palomo, A. Martínez Rodado, L. Ramos Ortiz de Zarate, C. Merino Argumánez, B. García Magallón, O. Rusinovich Lovgach, H. Godoy, M. Fernandez Castro, C. Isasi Zaragoza, C. Barbadillo, J. Sanz, J. L. Andreu Sánchez, J. Campos Esteban
|
|
2024 AB1537
|
MULTICENTRIC ANALYSIS OF RHEUMATOLOGIC ADVERSE EVENTS RELATED TO CANCER IMMUNOTHERAPY IN TWO SPANISH HOSPITALS,
A. Llobell-Uriel, I. Gonzalez-Mazon, S. Retamozo, C. Secada-Gómez, A. Martín-Gutiérrez, A. García Castaño, E. Gallardo-Diaz, A. Gómez-Centeno, L. Fernandez-Morales, J. Gratacós, R. Blanco
|
|
2024 AB1538
|
BACK TO THE CLINIC? EVALUATING PREGNANCY MANAGEMENT OUTCOMES IN VIRTUAL AND IN-PERSON CARE,
J. Tan, M. De Vera, N. Amiri
|
|
2024 POS0460
|
METABOLIC REWIRING PROMOTES ANTI-INFLAMMATORY EFFECTS OF GLUCOCORTICOIDS,
J. P. Auger, M. Zimmermann, M. Faas, U. Stifel, D. Chambers, B. Krishnacoumar, R. V. Taudte, C. Grund, C. Scholtysek, S. Uderhardt, M. Pascual Maté, C. Stoll, M. Böttcher, K. Palumbo-Zerr, M. Mangan, M. Dzamukova, M. Kieler, M. Hofmann, S. Blüml, G. Schabbauer, D. Mougiakakos, U. Sonnewald, F. Hartmann, D. Simon, A. Kleyer, A. Grüneboom, S. Finotto, E. Latz, J. Hofmann, G. Schett, J. Tuckermann, G. Krönke
|
|
2024 POS0461
|
IMMUNE RESPONSES TO HERPES ZOSTER VACCINE RESPONSES IN RHEUMATIC PATIENTS ON JAK INHIBITORS: INSIGHTS IN HUMORAL AND CELLULAR RESPONSE,
C. Sieiro Santos, J. Ordas Martínez, E. Robles Martín, X. Cásas Fernández, C. Álvarez Castro, A. López Robles, C. Díez, E. Diez Álvarez, J. M. García Ruíz de Morales
|
|
2024 POS0462
|
PRECLINICAL DEVELOPMENT OF KYV-201, AN INVESTIGATIONAL ALLOGENEIC ANTI-CD19 CAR T CELL FOR THE TREATMENT OF AUTOIMMUNE DISEASE,
A. Mahne, B. Kwong, J. Cheng, J. Wang, J. Banuelos, P. Starokadomskyy, S. Park, C. Gibson, S. Sengupta, S. Sandoval, J. Bravo, J. Flandez, S. Shah, A. Goodsell, Y. Zhang, I. Miller, B. Schultes, T. Van Blarcom
|
|
2024 POS0463
|
A NOVEL, ORAL, ALLOSTERIC INHIBITOR OF TYK2 DEMONSTRATES IN VITRO POTENCY, SELECTIVITY, AND IN VIVO EFFICACY IN MOUSE MODELS OF PSORIASIS,
R. Hussein, P. Tsuruda, S. Mortezaei, N. Ferdyan, C. Wegerski, K. Srinivasan, G. Hirst, N. Mozaffarian
|
|
2024 POS0464
|
SERUM PROTEOMIC ANALYSIS IDENTIFIES MARKERS ASSOCIATED WITH ANTI-CD19 CAR T THERAPEUTIC RESPONSE IN AUTOIMMUNE DISEASES,
J. Chou, R. Grieshaber-Bouyer, D. Bohr, C. Bergmann, J. Taubmann, F. Müller, A. Bozec, T. Rothe, A. Mackensen, J. Chung, G. Schett
|
|
2024 POS0465
|
A NOVEL THERAPEUTICALLY ACTIVE ANTI-TNFR2 AGONISTIC ANTIBODY PROMOTES TREG PROLIFERATION AND INDUCTION OF TREG FUNCTIONAL MARKERS,
T. Miyazaki, M. Maiti, I. Amit, D. Hamel, Q. Wu, R. Pena, K. Brendza, T. Chang, V. Guo, S. Kivimae, Y. Ofran, J. Zalevsky
|
|
2024 POS0466
|
OBEXELIMAB INHIBITS BCR SIGNALLING AND PATHOGENIC B CELL CHEMOTAXIS IN PATIENTS WITH IGG4-RELATED DISEASE,
T. Guy, H. Liu, V. Mahajan, C. Perugino, Z. S. Wallace, S. Quinn, M. Matijevic, A. Poma, D. Zach, J. H. Stone, S. Pillai
|
|
2024 POS0560
|
DYSFUNCTION OF ALVEOLAR EPITHELIAL CELL REPAIR IN HUMANIZED PULMONARY FIBROSIS MOUSE MODEL,
Z. H. LI, R. Mu
|
|
2024 POS0750
|
WHO PARTICIPATES IN AN ONLINE SYMPTOM CHECKER? CHARACTERISTICS, ATTRITION AND REPRESENTATIVENESS IN THE RHEUMATIC? STUDY,
F. Zegers, L. Qin, D. Selani, G. Gomon, T. D. Maarseveen, H. K. Glas, A. Van Tubergen, Y. Goekoop-Ruiterman, M. J. T. Reinders, E. B. Van den Akker, C. Baatenburg de Jong, L. Klareskog, B. Axnäs, E. Steyerberg, R. Bos, S. Le Cessie, R. Knevel
|
|
2024 POS0886
|
NO INCREASED RISKS OF SERIOUS INFECTIONS IN INFANTS AFTER IN-UTERO EXPOSURE TO TNF INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS INFORMING THE EULAR TASK FORCE ON ANTIRHEUMATIC DRUGS IN REPRODUCTION, PREGNANCY AND LACTATION,
L. Rüegg, S. Hamroun, A. Pluma Sanjurjo, M. Kramer, A. Finckh, F. Förger, Y. Meissner on behalf of EULAR task force QoC 012: Update of the EULAR points to consider for use of antirheumatic drugs in reproduction, pregnancy and lactation
|
|
2024 POS0888
|
PHARMACOKINETICS OF CERTOLIZUMAB PEGOL IN PREGNANCY: RESULTS FROM THE OPEN-LABEL, PHASE 1B CHERISH STUDY,
M. E. B. Clowse, R. J. E. M. Dolhain, S. Finzel, F. Förger, C. Glaser, A. Pluma Sanjurjo, L. Shaughnessy, J. Sidhu, J. Greenin, K. Rice, M. Teil
|
|
2024 POS0889
|
PATIENT RESEARCH PARTNER INVOLVEMENT IN RHEUMATOLOGY RESEARCH: A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2023 UPDATED EULAR RECOMMENDATIONS FOR THE INVOLVEMENT OF PATIENT RESEARCH PARTNERS,
K. Aouad, M. De Wit, M. Elhai, D. Benavent, H. Bertheussen, J. Primdahl, C. Zabalan, P. Studenic, L. Gossec
|
|
2024 POS0890
|
LONG-TERM CARDIO-VASCULAR RISK IN PATIENTS WITH RHEUMATIC DISEASES – RESULTS OF A 17 YEAR FOLLOW UP STUDY,
M. Fröhlich, M. Schmalzing, S. Stoerk, M. Gernert, H. Purucker, S. Kleinert, M. Breunig, P. P. Strunz, H. Labinsky, P. U. Heuschmann, V. Rücker, C. Morbach
|
|
2024 POS0891
|
CONTINUATION VERSUS TEMPORARY INTERRUPTION OF IMMUNOMODULATORY AGENTS DURING INFECTIONS: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL IN 1142 PATIENTS WITH INFLAMMATORY ARTHRITIS,
M. Opdam, N. Den Broeder, R. Van Crevel, J. Broen, L. M. Verhoef, A. A. Den Broeder
|
|
2024 POS0892
|
CLINICAL PREDICTIVE MODEL FOR INFECTION RISK IN CTD-ILD PATIENTS UNDERGOING CYCLOPHOSPHAMIDE PULSE THERAPY,
D. Huang, Y. Liu
|
|
2024 POS0893
|
PANEL OF SERUM BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF IDIOPATHIC INTERSTITIAL LUNG DISEASE AND INTERSTITIAL LUNG DISEASE-SECONDARY TO AUTOIMMUNE RHEUMATIC DISEASE,
E. Conticini, P. Cameli, C. V. Cotton, J. Lamb, L. Bergantini, S. Gangi, G. Montuori, S. Sugden, L. Spencer, B. Frediani, R. P. New, H. Chinoy, E. Bargagli, M. D’alessandro
|
|
2024 POS0894
|
SAFETY OF UPADACITINIB ACROSS RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS ENCOMPASSING 15,000 PATIENT-YEARS OF CLINICAL TRIAL DATA,
G. R. Burmester, S. B. Cohen, A. Deodhar, E. Mysler, A. Rubbert-Roth, Y. Tanaka, K. L. Winthrop, P. Nakasato, D. Coombs, A. Gara, N. Khan, B. Kovacs, S. Meerwein, J. R. Curtis
|
|
2024 POS0895
|
FAMILY PLANNING IN WOMEN AFFECTED BY RHEUMATOLOGICAL DISEASES: REAL-LIFE DATA FROM ITALY,
G. Carrea, M. Gerosa, M. Mosca, M. Padovan, S. Paolino, M. G. Anelli, R. Ramonda, C. Nalli, P. Rovere-Querini, E. Bellis, S. D’angelo, E. Fusaro, M. S. Chimenti, L. Santo, M. Gabini, G. Pazzola, F. Serale, C. Montecucco, F. Conti, R. F. Caporali
|
|
2024 POS0896
|
FACTORS ASSOCIATED WITH THE NEED FOR ASSISTED REPRODUCTIVE THERAPIES IN A SPANISH COHORT OF PATIENTS WITH RHEUMATIC DISEASES,
A. García Fernández, F. Rengifo García, R. Senosiain Echarte, Á. Navidad Miguel, M. Á. González-Gay, J. A. Martinez Lopez
|
|
2024 POS0897
|
CYTOMEGALOVIRUS INFECTION IN IMMUNOSUPPRESSED PATIENTS WITH RHEUMATOLOGIC DISEASE,
X. Y. Tay, C. Y. L. Lim, Y. J. Poh, A. Low, P. Z. B. Cherng, Z. Han
|
|
2024 POS0898
|
PREGNANT WOMEN ON TNFI MAY HAVE HIGHER RISK OF HOSPITALIZATION FOR INFECTIONS DURING GESTATION AND POSTPARTUM,
L. K. Flatman, S. Bernatsky, I. Malhamé, M. E. Beauchamp, Y. St-Pierre, O. Basso, A. Bérard, É. Vinet
|
|
2024 POS0899
|
FIRST-IN-HUMAN SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS DATA WITH MK-6194, A MODIFIED FORM OF INTERLEUKIN-2, DESIGNED TO SELECTIVELY ACTIVATE REGULATORY T-CELLS – SINGLE ASCENDING DOSE AND MULTIPLE ASCENDING DOSE TRIALS,
J. Scheid, A. Cunningham-Bussel, N. Kim, S. Agarwal, G. Nieddu, J. Cote, L. Lemoine, T. Decaestekar, L. Mendez, E. Paul, L. Love-Gregory, A. V. Contreras, L. Pang, G. Baltus, M. Beaumont, K. Shah, N. Higginson-Scott, K. Kis-Toth, K. Otipoby, J. L. Viney, E. Sicard, S. Rottey, J. S. Sundy, K. Vandyck, T. Laethem, P. Larson, S. Sutradhar, R. Wnek, T. Bueters, E. Lai, A. Stoch, M. Iwamoto, J. Robbins
|
|
2024 POS0900
|
EFFECTIVENESS OF DAPAGLIFLOZIN FOR RHEUMATIC AND MUSCULOSKELETAL DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE,
H. Hanaoka, J. Kikuchi, K. Hiramoto, M. Akiyama, S. Saito, Y. Kondo, Y. Kaneko
|
|
2024 POS0901
|
FACTORS ASSOCIATED WITH SUICIDAL IDEATION AMONG PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES: A CASE-CONTROL STUDY,
E. Von Schlichting, J. Dieris-Hirche, I. Redeker, X. Baraliakos, U. Kiltz
|
|
2024 POS0902
|
WHAT IS THE IMPACT OF CONFLICTING INFORMATION ON THE USE OF ANTI-RHEUMATIC DRUGS IN PREGNANCY AND BREASTFEEDING? LIKELIHOOD FOR APPREHENSION AND MEDICATION CESSATION REPORTED BY HEALTH CARE PROVIDERS IN THE GLOBAL PRAISE SURVEY,
K. Schreiber, C. Graversgaard, N. Agmon-Levin, S. Aguilera, A. Antovic, G. K. Bertsias, I. Bini, A. Bobirca, S. Capela, R. Cervera, N. Costedoat-Chalumeau, O. Etomi, J. Flint, J. E. Fonseca, R. Fritsch-Stork, F. Förger, I. Giles, B. Goulden, C. Götestam Skorpen, I. Gunnarsson, L. Gupta, H. S. Koksvik, L. Linde, J. Lykke, Y. Meissner, A. Moltó, L. Moore, M. Mosca, C. Nelson-Piercy, L. F. Perez, L. Raio, A. L. Rom, A. Rottenstreich, M. Saleh, S. Sciascia, A. Strangfeld, E. Svenungsson, M. G. Tektonidou, A. Tincani, A. Troldborg, J. Vojinovic, A. Voss, M. Wallenius, A. Zbinden, L. Andreoli on behalf of EULAR Study Group on Reproductive Health and Family Planning (ReHFaP)
|
|
2024 POS0903
|
ABATACEPT AND THE RISK OF MALIGNANCY: A META-ANALYSIS ACROSS DISEASE INDICATIONS,
B. Zuckerman, M. Gibson, R. Roy, M. Hughes, D. Mehta, M. A. Adas, K. Ng, S. Norton, M. Russell, A. Cope, J. Galloway
|
|
2024 POS0904
|
UNLOCKING PRECISION IN CAPILLAROSCOPY: EXTERNAL VALIDATION OF THE CAPI-SCORE ALGORITHM FOR ACCURATE PATTERN IDENTIFICATION IN NAILFOLD VIDEOCAPILLAROSCOPY,
G. Lledó, L. Sáez-Comet, M. Freire Dapena, M. A. Mesa Navas, M. Martín Cascón, A. Guillén-Del-Castillo, E. Martínez Robles, J. A. Todoli, C. P. Simeón-Aznar, D. C. Varela, G. Maldonado, A. Marín Ballvé, N. Longares Ibáñez, B. D. C. Gracia Tello, E. Ramos Ibañez
|
|
2024 POS0905
|
IMMUNE CELL-SPECIFIC CHARACTERIZATION OF HIGH-RESOLUTION COMPUTED TOMOGRAPHY (HRCT) PATTERNS IN INFLAMMATORY RHEUMATIC DISEASES WITH LUNG INVOLVEMENT: A STUDY IN NEWLY DIAGNOSED PATIENTS,
T. Hoffmann, M. Förster, P. Oelzner, C. Kroegel, U. Teichgräber, D. Renz, J. Böttcher, P. C. Schulze, G. Wolf, M. Franz, A. Pfeil
|
|
2024 POS0907
|
THE SIGNIFICANCE OF ANALYSED MILLIMETERS IN INTERPRETING NAILFOLD CAPILLAROSCOPY IMAGES,
B. D. C. Gracia Tello, L. Sáez-Comet, G. Lledó, M. Freire Dapena, M. A. Mesa Navas, M. Martín Cascón, A. Guillén-Del-Castillo, E. Martínez Robles, C. P. Simeón-Aznar, A. Marín Ballvé, F. J. Orti Cuerva, A. Rodríguez Trigueros, N. Longares Ibáñez, E. Ramos Ibañez
|
|
2024 POS0908
|
THE IMPACT OF ANTI-RO52 ANTIBODIES ON MICROCIRCULATION AND ORGAN INVOLVEMENT IN AUTOIMMUNE CONNECTIVE TISSUE DISEASES,
V. Bernardino, A. Rodrigues, M. Fernandes, A. Llado, M. Vicente, M. Botelho de Sousa, R. Vieira, R. Martinho, S. Dias, A. R. Gomes, A. Taulaigo, S. Guerreiro Castro, E. Patarata, H. Gruner
|
|
2024 POS0909
|
A PHASE 1 SINGLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF ZB002, AN ANTI-TNFΑ MAB DESIGNED FOR EXTENDED HALF-LIFE, IN HEALTHY VOLUNTEERS,
C. Sellwood, S. Wax, M. Gao, M. Matijevic, M. Yamashita, S. Yu, S. Arora, R. Kirk
|
|
2024 POS0910
|
INTENTIONS TO BREASTFEED, PATTERNS AND ATTITUDES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES IN MEXICO: A MULTICENTER STUDY,
I. Peláez-Ballestas, M. D. C. Canseco-Larios, A. C. Lobato-Belmonte, D. Ramos, L. Perez-Barbosa, L. De-la-Rosa, A. Carrasco-Chapa, A. Gastelum-Strozzi, G. Rodriguez-Orozco, A. G. Rodriguez-Flores, M. J. Morales-Graciano, M. F. Ramírez-Flores, C. M. Skinner-Taylor, A. Hernandez-Garduno on behalf of Grupo de estudio de Salud Reproductiva de Enfermedades Reumaticas Autoinmunes Mexico
|
|
2024 POS0911
|
REASONS FOR NON-RESPONSE TO TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS CLASSIFIED AS DIFFICULT TO TREAT (D2T),
F. Cosan, M. M. Sonkaya, I. E. Uluisik, S. D. Torun
|
|
2024 POS0912
|
A NOVEL SCORING SYSTEM TO PREDICT SERIOUS INFECTIONS IN PATIENTS WITH RHEUMATIC DISEASES RECEIVING PROLONGED, HIGH-DOSE GLUCOCORTICOID TREATMENT,
S. R. Choi, Y. J. Ha, J. K. Park, E. H. Kang, E. Y. Lee, Y. J. Lee, E. B. Lee, J. W. Park
|
|
2024 POS0913
|
EVALUATION OF THE IMPLEMENTATION OF THE EULAR RECOMMENDATION CHECK LIST FOR TRANSPARENT AND COMPREHENSIVE REPORTING OF ULTRASOUND STUDIES IN RHEUMATIC AND MUSCULOSKELETAL DISEASES,
P. Mandl, E. De Lorenzis, F. G. Lazzaro, B. Wildner, M. A. D’agostino
|
|
2024 POS0914
|
GLUCOCORTICOIDS IN PREGNANCY AND LACTATION: RESULTS OF THE SYSTEMATIC REVIEW INFORMING THE EULAR TASK FORCE ON ANTIRHEUMATIC DRUGS IN REPRODUCTION, PREGNANCY AND LACTATION,
S. Hamroun, A. Pluma Sanjurjo, L. Rüegg, M. Kramer, Y. Meissner, A. Finckh, F. Förger
|
|
2024 POS0915
|
HARMONISING CONSENSUS AND RELIABILITY STUDIES IN MUSCULOSKELETAL ULTRASOUND,
P. Mandl, S. M. D. Carstensen, L. Terslev, H. Keen, C. Pineda, M. A. D’agostino
|
|
2024 POS0916
|
DRUG SURVIVAL OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIS: DATA FROM FIVE COUNTRIES OF LATIN AMERICA,
D. Alpizar-Rodriguez, C. A. Isnardi, V. Rivera Terán, I. M. Laurindo, G. Pons-Estel, M. Haye Salinas, I. E. Exeni, R. N. Alvarado, G. Gomez, A. Brigante, M. Pinheiro, R. Ranza, G. Castro, V. Fernandes, C. Brenol, M. Antonio Araujo Da Rocha Loures, D. Vega-Morales, I. J. Colunga-Pedraza, S. Sicsik, M. A. Saavedra Salinas, J. C. Casasola, G. Avila, S. Cabrera-Villalba, P. Melgarejo, P. Pusineri, R. Aranda, P. Jara Gomez, M. Soto Estevez, C. Brunengo, D. Cordovilla, B. Acevedo, S. Consani-Fernández, S. Rostan, P. De Abreu Trigueros
|
|
2024 POS0917
|
CLINICAL USEFULNESS OF 18F-FDG PET/CT IN DISSECTING THE HETEROGENEITY OF PATIENTS WITH FUO AND IUO. RESULTS FROM A “REAL-LIFE” STUDY,
I. DI Cola, S. Bindoli, S. Desarnaud, P. Ruscitti, A. Kas, B. Fautrel
|
|
2024 POS0918
|
PRECONCEPTIONAL AND PREGNANCY CHARACTERISTICS IN PATIENTS WITH ANTI-RO ANTIBODIES IN A MULTIDISCIPLINARY RHEUMATOLOGY-OBSTETRICS AND GYNAECOLOGY CONSULTATION: A DESCRIPTIVE STUDY,
T. Blázquez-Sánchez, A. García Fernández, F. Rengifo Garcia, E. Heras Recuero, A. Torres-Roselló, R. Senosiain Echarte, Á. Navidad Miguel, M. Á. González-Gay, J. A. Martinez Lopez
|
|
2024 POS1054
|
MOST RHEUMATOID ARTHRITIS PATIENTS WITH 0 OR 1 TENDER AND SWOLLEN JOINT COUNT AND PATIENT GLOBAL ASSESSMENT GREATER THAN 3/10 HAVE POSITIVE SCREENING FOR FIBROMYALGIA, DEPRESSION, NECK PAIN, BACK PAIN FATIGUE AND JOINTS WITH LIMITED MOTION/DEFORMITY ON AN MDHAQ,
T. Pincus, R. Hunter, N. Rodwell
|
|
2024 POS1060
|
IMPROVED MANAGEMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN RHEUMATIC DISEASES USING A MULTIFACETED APPROACH CENTERED ON A CLINICAL DECISION SUPPORT SYSTEM,
H. Ozawa, C. Horikawa, H. Nakajima, M. Suda, M. Okada
|
|
2024 POS1196
|
BLOOD MONOCYTE FRACTION AND CT ATTENUATION VALUE OF BONE MARROW IN FEVER OF UNKNOWN ORIGIN; A RETROSPECTIVE ANALYSIS FOR DIFFERENTIATING ADULT ONSET STILL’S DISEASE AND INTRAVASCULAR LARGE B-CELL LYMPHOMA,
N. Oda, H. Matsui, N. Oya, A. Kiuchi, Y. Motomura, K. Komori, R. Hazue, K. Takagishi, R. Rokutanda
|
|
2024 POS1222
|
COMPUTATIONAL TRANSCRIPTOMIC ANALYSIS REVEALS DYSREGULATION OF THE NAD+ PATHWAY IN CHRONIC INFLAMMATORY RHEUMATIC DISEASES,
B. Vellón-García, M. Pérez-Rodriguez, M. Llamas-López, Á. A. Puerto-Nuñez, L. M. Sánchez-Mendoza, J. A. González-Reyes, J. A. Moreno, M. I. Burón, A. Llamas-Urbano, J. M. Martínez-Moreno, Y. Hanaee, I. Arias-de la Rosa, C. López-Medina, E. Collantes-Estevez, N. Barbarroja, A. Escudero-Contreras, C. Lopez-Pedrera, J. M. Villalba, C. Perez-Sanchez
|
|
2024 POS1320
|
FUNCTIONAL MAPPING OF AUTOIMMUNE PATIENTS BASED ON SERUM IMMUNE COMPLEXES REVEALS A COMMON TLR7/8 ENDOTYPE,
S. Hawtin, S. Dyball, C. André, S. Appenzeller, B. Bannert, H. Brunner, I. N. Bruce, E. Ferrero, A. Gernand, D. Kyburz, B. Maurer, R. Siegel, T. Shisha, J. Zierer, T. Junt
|
|
2024 POS1321
|
THE EFFECTS OF EVOLUTIONARY DIVERGENCE IN THE HUMAN LEUKOCYTE ANTIGEN REGION IN AUTOIMMUNE DISEASES,
R. Domínguez Rodríguez, M. Martínez Bueno, E. Carnero Montoro, G. Barturen, R. Díaz Peña, M. Alarcon-Riquelme on behalf of Genomics of Complex Diseases
|
|
2024 POS1322
|
IMID PATIENTS SHOW EXPANDED SENESCENT CD8 T-CELLS ASSOCIATED WITH LEVELS OF CIRCULATING INTERFERON GAMMA AND IL-6,
S. Bitoun, M. Naigeon, M. Roulleaux-Dugage, C. DE Oliveira, C. Berthot, X. Mariette, N. Chaput-Gras, G. Nocturne
|
|
2024 POS1323
|
IL-16 EXPRESSION IN RENAL IGA VASCULITIS AND THROMBOTIC MICROANGIOPATHY - A PILOT STUDY ON A POSSIBLE NOVEL ACTIVITY BIOMARKER,
A. Häyry, V. Oke, A. Larsson, E. Svenungsson, I. Gunnarsson, F. Faustini
|
|
2024 POS1380
|
TRANSFORMING RHEUMATOID ARTHRITIS CARE: A GROUNDBREAKING APPROACH TO PREDICTIVE TREATMENT OUTCOMES USING ARTIFICIAL INTELLIGENCE,
C. Ibañez, G. S. Rodríguez-Vargas, F. Rodriguez-Florido, P. Rodríguez-Linares, A. Rojas-Villarraga, P. Santos-Moreno
|
|
2024 POS1409
|
GENOME-WIDE ASSOCIATION STUDY FOR LOCI ASSOCIATED WITH POSITIVE ANTINUCLEAR ANTIBODIES IN A LARGE BIOBANK,
J. Cui, J. Yee, E. G. Oakes, H. Guan, L. Liang, K. Costenbader
|
|
2024 POS1410
|
LONG-ACTING DERIVATIVES OF A BACTERIAL IGG PROTEASE WITH REDUCED IMMUNOGENICITY FOR THE RAPID DEGRADATION OF IGG AUTOANTIBODIES,
M. Sauer, B. Dutzar, E. Frazier, K. Chan, D. Farrell, G. Robertson, Y. Song, E. Tarcha, E. Procko
|
|
